These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34108104)

  • 1. Effectiveness and safety of subcutaneous immunotherapy with standardized house dust mite extract for patients under the age of 5 years: A prospective cohort study.
    Hamada M; Saeki K; Tanaka I
    Allergol Int; 2021 Oct; 70(4):492-494. PubMed ID: 34108104
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.
    Batard T; Baron-Bodo V; Martelet A; Le Mignon M; Lemoine P; Jain K; Mariano S; Horiot S; Chabre H; Harwanegg C; Marquette CA; Corgier BP; Soh WT; Satitsuksanoa P; Jacquet A; Chew FT; Nony E; Moingeon P
    Allergy; 2016 Feb; 71(2):220-9. PubMed ID: 26485347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sublingual immunotherapy tablets in dust mite and pollen allergy.
    Bisyuk Y; DuBuske I; DuBuske LM
    Allergy Asthma Proc; 2021 Jan; 42(1):36-42. PubMed ID: 33404387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 mRNA levels in whole blood cells correlate with house dust mite allergen immunotherapy efficacy.
    Guéguen C; Luce S; Lombardi V; Baron-Bodo V; Moingeon P; Mascarell L
    Allergy; 2019 Nov; 74(11):2223-2226. PubMed ID: 30793324
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral allergy syndrome in shrimp and house dust mite allergies.
    Tuano KTS; Davis CM
    J Allergy Clin Immunol Pract; 2018; 6(6):2163-2164. PubMed ID: 29751156
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of cluster specific immunotherapy with a modified high-dose house dust mite extract.
    Nieto García A; Nevot Falcó S; Carrillo Díaz T; Cumplido Bonny JA; Izquierdo Calderón JP; Hernández-Peña J
    Eur Ann Allergy Clin Immunol; 2013 May; 45(3):78-83. PubMed ID: 23862396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of dust mite allergens.
    Cao H; Liu Z
    Mol Biol Rep; 2020 Aug; 47(8):6239-6246. PubMed ID: 32803501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom dynamics during repeated serial allergen challenge chamber exposures to house dust mite.
    Jacobs RL; Andrews CP; Ramirez DA; Rather CG; Harper N; Jimenez F; Martinez H; Manoharan M; Carrillo A; Gerardi M; Esch RE; He W; Ahuja SK
    J Allergy Clin Immunol; 2015 Apr; 135(4):1071-1075. PubMed ID: 25458003
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective comparison of a nonmodified and a modified mite extract for immunotherapy in children and adolescents.
    Hartmann D; Fischl A; Herrmann E; Schulze J; Schubert R; Zielen S
    Immunotherapy; 2019 Aug; 11(12):1015-1029. PubMed ID: 31319714
    [No Abstract]   [Full Text] [Related]  

  • 10. Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy.
    Tabar AI; Arroabarren E; Echechipía S; García BE; Martin S; Alvarez-Puebla MJ
    J Allergy Clin Immunol; 2011 Jan; 127(1):57-63, 63.e1-3. PubMed ID: 21211641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Der p 23: Clinical Relevance of Molecular Monosensitization in House Dust Mite Allergy.
    Matos Semedo F; Dorofeeva Y; Pires AP; Tomaz E; Taborda Barata L; Inácio F; Valenta R
    J Investig Allergol Clin Immunol; 2019; 29(4):314-316. PubMed ID: 30957762
    [No Abstract]   [Full Text] [Related]  

  • 12. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
    Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
    Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-life house dust mite allergens, childhood mite sensitization, and respiratory outcomes.
    Asselbergs IC; Eikenboom HC; Wartna JB; Koes BW
    Allergy; 2015 Sep; 70(9):1189. PubMed ID: 26311615
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical case of anaphylaxis with sublingual immunotherapy: house dust mite allergen.
    Van Dyken AM; Smith PK; Fox TL
    J Allergy Clin Immunol Pract; 2014; 2(4):485-6. PubMed ID: 25017545
    [No Abstract]   [Full Text] [Related]  

  • 16. Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
    Boonpiyathad T; Sokolowska M; Morita H; Rückert B; Kast JI; Wawrzyniak M; Sangasapaviliya A; Pradubpongsa P; Fuengthong R; Thantiworasit P; Sirivichayakul S; Kwok WW; Ruxrungtham K; Akdis M; Akdis CA
    Allergy; 2019 May; 74(5):976-985. PubMed ID: 30485456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for house-dust mite allergy.
    Nelson HS
    Allergy Asthma Proc; 2018 Jul; 39(4):264-272. PubMed ID: 30095391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Allergenic Potency of House Dust Extract and House Dust Mite Allergen Extract for Subcutaneous Allergen Immunotherapy.
    Du W; Fukano C; Yonemoto M; Matsuoka T; Masuyama K; Ohashi-Doi K
    Biol Pharm Bull; 2019; 42(4):601-606. PubMed ID: 30930419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural biology of mite allergens.
    Cui Y
    Mol Biol Rep; 2013 Jan; 40(1):681-6. PubMed ID: 23054022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.